New and updated respiratory syncytial virus (RSV) resources
Home / News & Opportunities / Latest news / Current post
August 13, 2025
The Australian Government Department of Health, Disability and Aging (the department) has released a number of updated resources to support the correct administration of RSV vaccines and monoclonal antibodies.
A single dose of the RSV vaccine, Abrysvo®, is recommended for women at 28 to 36 weeks of pregnancy and is available for free through the National Immunisation Program (NIP).
- Arexvy® must not be administered to pregnant women.
- Victoria is offering the RSV monoclonal antibody, Beyfortus™ (Nirsevimab) for free to eligible infants and children.
- Abrysvo® and Arexvy® must not be administered to infants or children.
- The department has produced a poster outlining the correct administration of RSV vaccines and monoclonal antibodies by cohort.
Updated resources include:
- RSV vaccine and monoclonal antibody poster – to facilitate appropriate choice of product
- RSV provider advice fact sheet
- RSV consumer advice fact sheet
- RSV frequently asked questions fact sheet.
For more information visit - Respiratory syncytial virus (RSV) vaccine | Australian Government Department of Health, Disability and Ageing
Latest news
My Way to Well-being is a free, six-week group program funded by SEMPHN and delivered by Better Place Australia, supporting participants with evidence-based strategies to enrich their mental health and wellbeing.
South Eastern Melbourne Primary Health Network’s (SEMPHN’s) 2025–2028 Health Needs Assessment has been updated with the latest data.
Funded by South Eastern Melbourne Primary Health Network (SEMPHN), Silverchain’s Care Coordination Support Service (CCSS) is supporting general practices across south east Melbourne to better care for patients with chronic and complex needs.
